Lanean...
Effects of addition of rituximab to chemotherapy on central nervous system events in patients with diffuse large B-cell lymphoma
The aim of this study was to evaluate whether the addition of rituximab to chemotherapy reduces central nervous system (CNS) events and to identify the risk factors associated with CNS involvement. Patients who were diagnosed with diffuse large B-cell lymphoma (DLBCL) between January, 1995 and Decem...
Gorde:
| Argitaratua izan da: | Mol Clin Oncol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486828/ https://ncbi.nlm.nih.gov/pubmed/26171174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.546 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|